Addus HomeCare Co. (NASDAQ:ADUS) Given Average Rating of “Buy” by Brokerages

Addus HomeCare Co. (NASDAQ:ADUS) has been assigned a consensus rating of “Buy” from the eleven ratings firms that are covering the stock, Marketbeat reports. One analyst has rated the stock with a sell recommendation, eight have given a buy recommendation and two have issued a strong buy recommendation on the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $134.22.

Several brokerages have recently issued reports on ADUS. Macquarie reissued an “outperform” rating and issued a $139.00 price objective on shares of Addus HomeCare in a report on Monday, November 4th. Oppenheimer increased their target price on Addus HomeCare from $145.00 to $150.00 and gave the company an “outperform” rating in a report on Friday. Stephens lifted their price target on Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 6th. KeyCorp initiated coverage on shares of Addus HomeCare in a research note on Friday, October 11th. They set an “overweight” rating and a $150.00 price objective for the company. Finally, Citizens Jmp upgraded Addus HomeCare to a “strong-buy” rating in a report on Monday, December 16th.

Addus HomeCare Stock Performance

Shares of NASDAQ ADUS opened at $130.62 on Friday. The company has a market cap of $2.37 billion, a price-to-earnings ratio of 29.89, a PEG ratio of 1.73 and a beta of 1.00. Addus HomeCare has a fifty-two week low of $85.94 and a fifty-two week high of $136.72. The business’s 50 day moving average price is $126.10 and its 200-day moving average price is $127.03.

Addus HomeCare (NASDAQ:ADUS) last announced its earnings results on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.28 by $0.02. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The business had revenue of $289.80 million for the quarter, compared to analysts’ expectations of $289.42 million. During the same quarter last year, the firm earned $1.03 EPS. The business’s revenue for the quarter was up 7.1% on a year-over-year basis. Sell-side analysts predict that Addus HomeCare will post 4.58 earnings per share for the current year.

Insider Buying and Selling at Addus HomeCare

In other Addus HomeCare news, CEO R Dirk Allison sold 25,000 shares of the company’s stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total value of $3,119,000.00. Following the transaction, the chief executive officer now owns 79,397 shares of the company’s stock, valued at approximately $9,905,569.72. This represents a 23.95 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Roberton James Stevenson sold 2,250 shares of the firm’s stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $121.00, for a total transaction of $272,250.00. Following the completion of the transaction, the executive vice president now directly owns 10,217 shares of the company’s stock, valued at $1,236,257. This represents a 18.05 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 39,750 shares of company stock valued at $4,930,750. Company insiders own 4.60% of the company’s stock.

Hedge Funds Weigh In On Addus HomeCare

Institutional investors have recently modified their holdings of the company. Point72 Asset Management L.P. grew its position in Addus HomeCare by 73.4% during the second quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company’s stock worth $86,598,000 after buying an additional 315,602 shares in the last quarter. Millennium Management LLC raised its stake in shares of Addus HomeCare by 412.7% in the second quarter. Millennium Management LLC now owns 316,418 shares of the company’s stock valued at $36,739,000 after acquiring an additional 254,705 shares during the last quarter. Wasatch Advisors LP raised its holdings in shares of Addus HomeCare by 11.8% in the third quarter. Wasatch Advisors LP now owns 1,043,240 shares of the company’s stock valued at $138,782,000 after buying an additional 110,010 shares during the last quarter. Ghisallo Capital Management LLC acquired a new position in shares of Addus HomeCare during the second quarter worth approximately $11,611,000. Finally, Principal Financial Group Inc. increased its position in Addus HomeCare by 17.5% in the third quarter. Principal Financial Group Inc. now owns 505,853 shares of the company’s stock worth $67,293,000 after purchasing an additional 75,409 shares during the period. Institutional investors own 95.35% of the company’s stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.